Mason Morfit
 | This article needs more links to other articles to help integrate it into the encyclopedia. (March 2014) |
 | The topic of this article may not meet Wikipedia's general notability guideline. (September 2014) |
G. Mason Morfit is CFA and president of ValueAct Capital. He was appointed on Board of Directors of Microsoft in March-2014.[1][2]
Education
Morfit has B.A. from Princeton University and he is a CFA charter holder. [clarification needed]
Career
Morfit joined the ValueAct Capital in January 2001. Prior to that he worked in equity research for Credit Suisse First Boston. He is a director of Valeant Pharmaceuticals International and a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., MSD Performance, Inc. and Solexa, Inc.[3]
References
 | This article about a United States businessperson is a stub. You can help Wikipedia by expanding it. |